the aim of the present study was to identify and characterize the sites of pcp action ( sigma and/or pcp receptors ) in human peripheral blood leukocytes ( pbl ) using [ 3h ] haloperidol or 1,3 di ( 2- ( [ 5-3h ] tolyl ) guanidine ( [ 3h ] dtg ) to specifically label sigma receptors and 3,4- [ 3h ] - ( n ) - [ 1- ( 2-thienyl ) -cyclohexyl ] -piperidine ( [ 3h ] tcp ) to specifically label pcp receptors .
C0086418
human
C3538902
di